Literature DB >> 2213182

Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings.

N Tamaki1, H Ohtani, Y Yonekura, R Nohara, H Kambara, C Kawai, K Hirata, T Ban, J Konishi.   

Abstract

To identify reversible defects, reinjection of a small amount of thallium-201 (201Tl) following 3-hr delayed imaging was performed in 60 patients with coronary artery disease who had perfusion abnormalities on their post-exercise 201Tl images. Thallium-201 uptake was visually scored and judged as normal (Group 1), reversible defect (Group II), new fill-in after reinjection (Group IIIa) and no fill-in even after reinjection (Group IIIb). New fill-in after reinjection was observed in 27 segments of the 85 segments (32%), showing persistent defect on the stress and delayed images. The wall motion in Group IIIa was worse than Group II but better than Group IIIb. Group IIIa showed Q-wave on ECG more often (69%) than Group II (27%) (p less than 0.01), but less often than Group IIIb (85%) (p less than 0.05). These data indicate that the reinjection 201Tl imaging often identifies new fill-in in the areas of no redistribution on the delayed images and it may hold promise for assessing tissue viability which the conventional imaging may underestimate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213182

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  30 in total

1.  Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphy.

Authors:  Tsuyoshi Fukuda; Masatoshi Ishibashi; Tatsuo Yokoyama; Masaki Otaki; Tohru Shinohara; Yoshihide Nakamura; Toshiharu Miyake; Takashi Kudoh; Hidetaka Oku
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  The clinical impact of thallium-201 reinjection scintigraphy for detection of myocardial viability.

Authors:  A F Kuijper; H W Vliegen; E E van der Wall; W P Oosterhuis; A H Zwinderman; B L van Eck-Smit; M G Niemeyer; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1992

3.  Viable myocardium and reinjection of thallium.

Authors:  S R Underwood; D J Pennell
Journal:  Br Heart J       Date:  1992-12

4.  Usefulness of reinjection image for evaluating viable myocardium in the infarcted zone on exercise thallium-201 SPECT.

Authors:  S Tomiguchi; M Takahashi; O Shimomura; A Kojima; M Hara; Y Koga; K Minoda; H Yasue; K Hayasaki
Journal:  Ann Nucl Med       Date:  1991-11       Impact factor: 2.668

5.  PET reflections.

Authors:  U Buell
Journal:  Eur J Nucl Med       Date:  1991

Review 6.  BMIPP compared with thallium redistribution.

Authors:  J Taki; I Matsunari; K Nakajima; N Tonami
Journal:  Int J Card Imaging       Date:  1999-02

7.  Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest-redistribution thallium-201 scintigraphy.

Authors:  A Cuocolo; S Maurea; L Pace; E Nicolai; A Nappi; M Imbriaco; B Trimarco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-12

8.  The incidence of discrepant regional myocardial uptake between 201 thallium and 123 I-BMIPP SPECT in patients with coronary heart disease.

Authors:  Kenji Ueshima; Tomohisa Miyakawa; Yasuyo Taniguchi; Osamu Nishiyama; Takehiko Musha; Masahiko Saitoh; Junnya Kamata; Toshiya Okajima; Mami Aisaka; Masayuki Nagamine; Katsuhiko Hiramori
Journal:  Int J Cardiovasc Imaging       Date:  2002-08       Impact factor: 2.357

Review 9.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

10.  Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism.

Authors:  M Kawamoto; N Tamaki; Y Yonekura; E Tadamura; Y Fujibayashi; Y Magata; R Nohara; S Sasayama; K Ikekubo; H Kato
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.